Cargando…
Novel αO-conotoxin GeXIVA[1,2] Nonaddictive Analgesic with Pharmacokinetic Modelling-Based Mechanistic Assessment
αO-conotoxin GeXIVA[1,2] was isolated in our laboratory from Conus generalis, a snail native to the South China Sea, and is a novel, nonaddictive, intramuscularly administered analgesic targeting the α9α10 nicotinic acetylcholine receptor (nAChR) with an IC(50) of 4.61 nM. However, its pharmacokinet...
Autores principales: | Zhu, Xiaoyu, Yuan, Mei, Wang, Huanbai, Zhangsun, Dongting, Yu, Gang, Che, Jinjing, Luo, Sulan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505004/ https://www.ncbi.nlm.nih.gov/pubmed/36145535 http://dx.doi.org/10.3390/pharmaceutics14091789 |
Ejemplares similares
-
The α9α10 Nicotinic Acetylcholine Receptor Antagonist αO-Conotoxin GeXIVA[1,2] Alleviates and Reverses Chemotherapy-Induced Neuropathic Pain
por: Wang, Huanbai, et al.
Publicado: (2019) -
αO-Conotoxin GeXIVA Inhibits the Growth of Breast Cancer Cells via Interaction with α9 Nicotine Acetylcholine Receptors
por: Sun, Zhihua, et al.
Publicado: (2020) -
Differential Expression of Nicotine Acetylcholine Receptors Associates with Human Breast Cancer and Mediates Antitumor Activity of αO-Conotoxin GeXIVA
por: Sun, Zhihua, et al.
Publicado: (2020) -
Lyophilization Serves as an Effective Strategy for Drug Development of the α9α10 Nicotinic Acetylcholine Receptor Antagonist α-Conotoxin GeXIVA[1,2]
por: Li, Zhiguo, et al.
Publicado: (2021) -
Preparation of uniform-sized GeXIVA[1,2]-loaded PLGA microspheres as long-effective release system with high encapsulation efficiency
por: Li, Lu, et al.
Publicado: (2022)